arrow
A

Aseel Alsouqi

james cancer hospital & solove research institute
H指数:10
被引数:324

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation

一项关于Duvelisib与Nivolumab联合治疗弥漫性大B细胞淋巴瘤、转化性滤泡性淋巴瘤和Richter转化的I期研究

2025-12-010
PRE
Outcomes of Patients with Chronic Lymphocytic Leukemia Discontinuing Bruton Tyrosine Kinase Inhibitors Due to Adverse Effects

因不良反应而停用布托替尼的慢性淋巴细胞白血病患者结局

BLOOD
IF23.1
2024-11-050
PRE
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis

嵌合抗原受体T细胞治疗继发性中枢神经系统淋巴瘤的多中心分析

2024-05-203
PRE
Critics role of IL-21 and T follicular helper cells in hypertension and vascular dysfunction
2019-06-0634
OA